000 | 01955 a2200565 4500 | ||
---|---|---|---|
005 | 20250516233435.0 | ||
264 | 0 | _c20150527 | |
008 | 201505s 0 0 eng d | ||
022 | _a1932-6203 | ||
024 | 7 |
_a10.1371/journal.pone.0107006 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPeterson, Kenneth R | |
245 | 0 | 0 |
_aA cell-based high-throughput screen for novel chemical inducers of fetal hemoglobin for treatment of hemoglobinopathies. _h[electronic resource] |
260 |
_bPloS one _c2014 |
||
300 |
_ae107006 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntigens, CD34 _xmetabolism |
650 | 0 | 4 |
_aBone Marrow Cells _xdrug effects |
650 | 0 | 4 | _aChromosomes, Artificial, Yeast |
650 | 0 | 4 | _aDrug Discovery |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 |
_aErythroid Precursor Cells _xdrug effects |
650 | 0 | 4 |
_aFetal Hemoglobin _xbiosynthesis |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 | _aGene Targeting |
650 | 0 | 4 | _aGenes, Reporter |
650 | 0 | 4 | _aGenetic Loci |
650 | 0 | 4 |
_aGenetic Vectors _xgenetics |
650 | 0 | 4 |
_aHemoglobinopathies _xdrug therapy |
650 | 0 | 4 | _aHigh-Throughput Screening Assays |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 |
_abeta-Globins _xbiosynthesis |
650 | 0 | 4 |
_agamma-Globins _xbiosynthesis |
700 | 1 | _aCosta, Flávia C | |
700 | 1 | _aFedosyuk, Halyna | |
700 | 1 | _aNeades, Renee Y | |
700 | 1 | _aChazelle, Allen M | |
700 | 1 | _aZelenchuk, Lesya | |
700 | 1 | _aFonteles, Andrea H | |
700 | 1 | _aDalal, Parmita | |
700 | 1 | _aRoy, Anuradha | |
700 | 1 | _aChaguturu, Rathnam | |
700 | 1 | _aLi, Biaoru | |
700 | 1 | _aPace, Betty S | |
773 | 0 |
_tPloS one _gvol. 9 _gno. 9 _gp. e107006 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0107006 _zAvailable from publisher's website |
999 |
_c24194958 _d24194958 |